Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 4469 (miR-4469) is a small, single-stranded, non-coding RNA classified as a microRNA that modulates gene expression at the post-transcriptional level by interacting with messenger RNAs, typically leading to their degradation or translational repression[3]. It functions as a tumor suppressor in colorectal cancer, where it is more highly expressed in normal colon tissue than in tumor tissue. Increased miR-4469 levels are associated with inhibition of colorectal cancer cell proliferation and migration and improved patient survival. The primary mechanism appears to be the regulation of inflammatory cell infiltration in tumor tissue, and miR-4469 expression affects the expression of target genes including SLC2A3, FGR, PLEKHO2, and MYO1F[1]. Although research describes its tumor suppressive properties, current evidence does not suggest it is a direct therapeutic drug target or receptor, but rather a candidate biomarker for cancer prognosis and biological research[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 4469 (miR-4469).